# Lead4Life PPP 2026 – Lead-212 Radiopharmaceuticals Program

**Funder:** KWF
**Budget:** €0.5M–€2M per project (total program: €5M)
**Deadline:** 22 September 2026 (12:00 noon; full proposal phase. Matchmaking phase precedes full proposal submission.)
**Duration:** Up to 4 years
**Consortium:** Required — public-private partnership consortium; Consortium Agreement between all participants is mandatory
**Application:** 2-stage: matchmaking phase → full proposal (deadline 22 Sep 2026)
**Frequency:** One-off
**Eligible countries:** NL
**Official call:** https://www.kwf.nl/en/forresearchers/funding/lead4life
**Last verified:** 18 June 2026

## Eligibility & scope

PPP proposals for lead-212 production/supply chain or enabling technologies for clinical introduction of Pb-212 radiopharmaceuticals. Requires active private-party participation (Health~Holland PPP rules), a Consortium Agreement, and compliance with RVO 'no undertaking in difficulty' declaration. Dutch-language summary required for patient advisory review. Netherlands-based institutions; unregistered institutes must register in KWF GMS ≥6 weeks before deadline.

## Summary

The KWF Lead4Life PPP 2026 funds public-private partnerships developing lead-212 radiopharmaceuticals, with budgets of €0.5-€2 million per project (total programme: €5M). The call targets Dutch research institutions and commercial partners collaborating on production supply chains or enabling technologies for clinical Pb-212 introduction. This is a one-off, two-stage call with mandatory consortium membership and strict compliance requirements including RVO declarations and patient advisory review.

## Who should apply

- Dutch research institutions (academic medical centres, hospital institutes, university departments) with clinical radiopharmaceutical expertise
- Commercial partners (pharmaceutical, biotech, or radiochemistry manufacturers) committed to supply-chain or technology development
- Consortium leads with experience managing multi-stakeholder agreements and Health~Holland PPP compliance
- Projects focused on lead-212 production capacity, supply logistics, or clinical-translation enablers rather than pure science
- Applicants able to register in KWF GMS system at least 6 weeks before the 22 September 2026 deadline

## Key dates

- Full proposal deadline: 22 September 2026, 12:00 noon (preceded by matchmaking phase)
- Up to four-year project duration
- One-off call; no subsequent rounds planned

## Tips for applicants

- Form your consortium before entering the matchmaking phase; KWF expects all partners to be aligned on supply-chain or technology scope, not exploratory collaborations.
- Prepare a Dutch-language patient summary for KWF's patient advisory review, this is mandatory and shaped differently from standard research abstracts.
- Document RVO 'no undertaking in difficulty' compliance explicitly in your application; KWF audits this and late corrections stall review.

## Frequently asked questions

### What is the budget for the KWF Lead4Life PPP 2026 call?

Up to €2 million per project, with a total programme budget of €5 million. The typical range is €0.5-€2 million depending on project scope.

### Who must be in a Lead4Life PPP consortium?

At least one Dutch research institution and one active private-sector partner (manufacturer, biotech, or pharmaceutical company). A formal Consortium Agreement is mandatory for all participants.

### What is the matchmaking phase?

An initial stage where potential consortium members are brought together before the full proposal deadline; full proposals are due 22 September 2026.

### Do I need to be based in the Netherlands to apply?

Yes, eligible organisations must be Netherlands-based. Unregistered institutes must register in KWF GMS at least 6 weeks before the deadline.

### What research focus does Lead4Life PPP support?

Lead-212 radiopharmaceutical production, supply-chain development, or clinical-translation enabling technologies; projects must have clear private-sector participation aligned with commercial viability.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/kwf-lead4life-ppp-2026-lead-212-radiopharmaceuticals-p) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.